Special Anniversary Offer: Vanishing Tomorrow - Your Chance to Save 80%
Here is the latest financial fact sheet of CHEMO PHARMA. For more details, see the CHEMO PHARMA quarterly results and CHEMO PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.6 |
No. of shares | m | 1.50 |
1 Week | % | 4.9 |
1 Month | % | 37.6 |
1 Year | % | 116.1 |
52 week H/L | Rs | 87.0/27.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
CHEMO PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 40 | 11 | 36 | 49 | 49 | |
Low | Rs | 11 | 6 | 5 | 18 | 29 | |
Sales per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Earnings per share (Unadj.) | Rs | 1.4 | 2.8 | 1.7 | 3.7 | 0.3 | |
Diluted earnings per share | Rs | 1.4 | 2.8 | 1.7 | 3.7 | 0.3 | |
Cash flow per share (Unadj.) | Rs | 1.4 | 2.9 | 1.8 | 3.9 | 0.4 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 68.9 | 71.6 | 73.3 | 77.0 | 77.3 | |
Adj. book value per share | Rs | 68.9 | 71.6 | 73.3 | 77.0 | 77.3 | |
Shares outstanding (eoy) | m | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | |
Price / Sales ratio | x | 0 | 0 | 0 | 0 | 0 | |
Avg P/E ratio | x | 18.3 | 2.9 | 12.3 | 9.0 | 124.4 | |
P/CF ratio (eoy) | x | 17.9 | 2.8 | 11.3 | 8.7 | 97.1 | |
Price / Book Value ratio | x | 0.4 | 0.1 | 0.3 | 0.4 | 0.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 38 | 12 | 31 | 50 | 59 | |
Total wages/salary | Rs m | 2 | 2 | 1 | 1 | 1 |
CHEMO PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 0 | 0 | 0 | 0 | 0 | |
Other income | Rs m | 8 | 10 | 7 | 9 | 7 | |
Total revenues | Rs m | 8 | 10 | 7 | 9 | 7 | |
Gross profit | Rs m | -6 | -5 | -3 | -5 | -6 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit before tax | Rs m | 3 | 5 | 3 | 4 | 1 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 1 | 1 | -2 | 0 | |
Profit after tax | Rs m | 2 | 4 | 3 | 6 | 0 | |
Gross profit margin | % | 0 | 0 | 0 | 0 | 0 | |
Effective tax rate | % | 18.9 | 16.0 | 19.5 | -53.4 | 35.5 | |
Net profit margin | % | 0 | 0 | 0 | 0 | 0 |
CHEMO PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 85 | 89 | 110 | 63 | 61 | |
Current liabilities | Rs m | 1 | 2 | 1 | 1 | 0 | |
Net working cap to sales | % | 0 | 0 | 0 | 0 | 0 | |
Current ratio | x | 93.8 | 40.3 | 189.0 | 58.3 | 306.4 | |
Inventory Days | Days | 0 | 0 | 0 | 0 | 0 | |
Debtors Days | Days | 0 | 0 | 0 | 0 | 0 | |
Net fixed assets | Rs m | 19 | 21 | 1 | 51 | 53 | |
Share capital | Rs m | 15 | 15 | 15 | 15 | 15 | |
"Free" reserves | Rs m | 88 | 92 | 95 | 101 | 101 | |
Net worth | Rs m | 103 | 107 | 110 | 116 | 116 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 104 | 110 | 111 | 114 | 114 | |
Interest coverage | x | 255.0 | 0 | 0 | 0 | 6.6 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0 | 0 | 0 | 0 | 0 | |
Return on assets | % | 2.0 | 3.8 | 2.3 | 4.9 | 0.5 | |
Return on equity | % | 2.0 | 3.9 | 2.3 | 4.8 | 0.4 | |
Return on capital | % | 2.5 | 4.6 | 2.8 | 3.2 | 0.7 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
CHEMO PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -55 | 48 | -4 | -3 | -7 | |
From Investments | Rs m | 8 | 10 | -2 | 10 | 6 | |
From Financial Activity | Rs m | 0 | 0 | 20 | -21 | -1 | |
Net Cashflow | Rs m | -47 | 58 | 14 | -15 | -1 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
COMP SEC: Neha Vora | YEAR OF INC: 1942 | BSE CODE: 506365 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare CHEMO PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.